Trazodone HCl

DRUG5 trials

Sponsors

Labopharm Inc., London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Conditions

BioavailabilityChronic Kidney Disease (CKD)HealthyHealthy SubjectsOlder Adults (65 Years and Older)Pharmacokinetics

Phase 1

Comparative Bioavailability Study of Extended-release and Immediate-release Trazodone in Healthy Adult Volunteers

CompletedNCT00839072

Labopharm Inc.Healthy

Start: 2009-02-28End: 2009-03-31Updated: 2012-04-27

Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy Volunteers

CompletedNCT01121913

Labopharm Inc.Healthy

Start: 2005-03-31Updated: 2012-04-27

A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets (Administered Three Times Daily)

CompletedNCT01121900

Labopharm Inc.Healthy

Start: 2008-06-30End: 2008-07-31Updated: 2012-04-27

A Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets and 100 mg Trazodone Hydrochloride Immediate-release Tablets at Steady State

CompletedNCT01121926

Labopharm Inc.Bioavailability, Healthy Subjects, Pharmacokinetics

Start: 2008-01-31End: 2008-03-31Updated: 2012-04-30

Unknown Phase

Trazodone and the Risk of Serious Adverse Events

CompletedNCT07381101

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sChronic Kidney Disease (CKD), Older Adults (65 Years and Older)

Start: 2008-01-01End: 2025-03-31Updated: 2026-03-05